Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.

Braz J Psychiatry

Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Published: January 2020

Cannabis is the most commonly used illegal drug, and is associated with well-documented adverse health outcomes, both acute and chronic. Cannabis use prevalence in Brazil is lower than in high-use regions in the Americas (e.g., North America), but concentrated among young people. Frameworks for cannabis control are increasingly shifting towards public health-oriented principles, with some countries undertaking respective policy reforms. These frameworks require a continuum of population-level interventions (e.g., prevention and treatment) including targeted prevention of adverse health outcomes among users. In this context, and based on examples from other health fields, an international expert group developed the evidence-based Lower-Risk Cannabis Use Guidelines (LRCUG), originally for Canada, including a set of 10 recommendations based on systematic data reviews and expert consensus methods. The LRCUG form a scientific population-health prevention tool to reduce adverse public health impacts for broad application among cannabis users. In Canada, the LRCUG have been formally endorsed and are supported by leading national health organizations and government authorities within the continuum of cannabis interventions. As the LRCUG are being internationalized, this paper introduces the LRCUG's concept and content - including their original recommendations translated into Portuguese - to the Brazilian context as an evidence-based population-level intervention tool for uptake, dissemination, and discussion. Sociocultural adaptation may be required for meaningful implementation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899352PMC
http://dx.doi.org/10.1590/1516-4446-2018-0239DOI Listing

Publication Analysis

Top Keywords

lower-risk cannabis
8
cannabis guidelines
8
adverse health
8
health outcomes
8
cannabis
7
health
6
introducing evidence-based
4
evidence-based population
4
population health
4
health tool
4

Similar Publications

Tobacco, cannabis, alcohol, and polysubstance use disparities among sexual identity groups of US young adult women and men.

Addict Behav Rep

December 2024

Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.

Background: Sexual minority young adults (SMYAs) display higher rates of polysubstance use (i.e., current use of multiple substances) than their heterosexual peers, but limited research has explored differences by gender and specific sexual identity.

View Article and Find Full Text PDF

Background: Canada has one of the highest prevalence of cannabis use globally, particularly among young adults aged 20-24 (50%) and youth aged 16-19 (37%). In 2018, Canada legalized recreational cannabis with the aim of protecting youth by restricting their access and raising public awareness of health risks. However, there has been limited qualitative research on the perceptions of harms associated with youth cannabis use since legalization, which is crucial for developing effective harm reduction strategies.

View Article and Find Full Text PDF

Introduction: Effective interventions show heterogeneity in treatment response. Addressing this heterogeneity involves identifying which intervention works best for whom. One method to address this heterogeneity identifies treatment-subgroup interactions to determine which of two interventions has greater effect for certain individuals based on their profile of pre-treatment characteristics.

View Article and Find Full Text PDF

Substance Use among Youth Presenting to the Pediatric Emergency Department.

J Med Toxicol

October 2024

Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, 150 East 42nd Street, 9th floor, New York, NY, 10017, USA.

Objective: Our primary objective was to determine the frequency and type of substance use in youth presenting to our pediatric ED (PED). Our secondary objective was to identify characteristics associated with higher-risk substance use.

Methods: We conducted a tablet-based, anonymous, self-administered screening for substance use using a modified version of the Screening to Brief Intervention (S2BI) tool among a convenience sample of 383 patients 12-21 years presenting to an urban, academic PED from February to July 2023.

View Article and Find Full Text PDF

The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol.

Int J Drug Policy

November 2024

Center for Addictive Disorders, Department of Adult Psychiatry, Psychiatric University Hospital Zurich, University of Zurich, Selnaustrasse 9, 8001 Zurich, Switzerland.

Background And Aims: Recreational use of cannabis is illegal in most countries. Despite this, it is the third most commonly used psychoactive substance worldwide. As a result of this discrepancy, a growing number of countries have begun to reassess their legal approach to cannabis in recent years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!